
Avient Corp (AVNT) Stock Forecast & Price Target
Avient Corp (AVNT) Analyst Ratings
Bulls say
Avient Corp reported a 5% increase in organic sales, reflecting strong demand for its diverse range of chemical and plastic-based products. Notably, the healthcare segment has demonstrated robust performance, achieving double-digit growth for six consecutive quarters and a year-over-year increase of 14% in the first half of 2025. Additionally, four out of nine key end markets, representing 40% of the company's sales, are experiencing growth this year, which underpins the positive outlook for Avient's financial performance.
Bears say
Avient Corp has experienced a decline in organic sales, with a notable decrease of approximately 2% in 1Q24, despite showing some recovery with 5% year-over-year growth in 2Q and 9% growth in 3Q. The company faces weakening demand in the chemicals sector, particularly since mid-2025, raising concerns about potential volume declines in the latter half of 2025. Despite the recent depreciation of the dollar, which could provide a temporary boost, the overall outlook remains cautious due to underlying demand weaknesses and inconsistent sales performance.
This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.
Avient Corp (AVNT) Analyst Forecast & Price Prediction
Start investing in Avient Corp (AVNT)
Order type
Buy in
Order amount
Est. shares
0 shares